Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1007/BF00187244PMID 3124159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral serotonin antagonists: Failure to antagonize serotonin in brain areas receiving a prominent serotonergic input

  2005cited by this paper
• Involvement of 5-HT2 receptors in the LSD- and L-5-HTP-induced suppression of lordotic behavior in the female rat

  2005cited by this paper
• 5-Methoxy-N,N-dimethyltryptamine: Spinal cord and brainstem mediation of excitatory effects on acoustic startle

  2004cited by this paper
• Effects of 6-hydroxydopamine lesions of locus coeruleus on startle in rats

  2004cited by this paper
• Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

  2004influential reference
• Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat

  2004cited by this paper
• paraChlorophenylalanine potentiates facilitatory effects of mescaline on shuttlebox escape/avoidance in rats

  2004cited by this paper
• Psychopharmacology: The third generation of progress

  1988cited by this paper
• The design and calibration of a startle measurement system.

  1986cited by this paper
• Serotonin receptor subtype agonists: differential effects on sensorimotor reactivity measured with acoustic startle.

  1986cited by this paper
• Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.

  1986cited by this paper
• Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity.

  1986cited by this paper
• The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.

  1985cited by this paper
• Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding.

  1985cited by this paper
• Central noradrenergic involvement in yohimbine excitation of acoustic startle: effects of DSP4 and 6-OHDA.

  1985cited by this paper
• Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

  1985cited by this paper
• Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

  1985cited by this paper
• Mechanistic studies on DOM as a discriminative stimulus.

  1985cited by this paper
• Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

  1985cited by this paper
• Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

  1984cited by this paper
• The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

  1984cited by this paper
• 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

  1984cited by this paper
• Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.

  1984cited by this paper
• A characterization of LSD-antagonist effects of pirenperone in the rat.

  1983cited by this paper
• Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.

  1983cited by this paper
• LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.

  1983cited by this paper
• Behavior and binding: correlations between alpha 1-adrenergic stimulation of acoustic startle and alpha 1-adrenoceptor occupancy and number in rat lumbar spinal cord.

  1983cited by this paper
• Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.

  1983cited by this paper
• Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.

  1983cited by this paper
• DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.

  1983cited by this paper
• Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.

  1982cited by this paper
• [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

  1982cited by this paper
• A primary acoustic startle circuit: lesion and stimulation studies

  1982cited by this paper
• In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.

  1982cited by this paper
• Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.

  1981cited by this paper
• Spinal modulation of the acoustic startle response: the role of norepinephrine, serotonin and dopamine.

  1981cited by this paper
• Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.

  1980influential reference
• Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study.

  1980cited by this paper
• Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle.

  1980cited by this paper
• Acute and chronic LSD effects on rat startle: data supporting an LSD--rat model of schizophrenia.

  1980cited by this paper
• Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline.

  1980cited by this paper
• Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine.

  1980cited by this paper
• The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.

  1980cited by this paper
• Acute and chronic LSD effects on rat startle: data supporting an LSD--rat model of schizophrenia.

  1980cited by this paper
• Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli.

  1980cited by this paper
• Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain.

  1980cited by this paper
• Serotonergic facilitation of facial motoneuron excitation.

  1979cited by this paper
• Mescaline increases startle responding equally in normal and raphe-lesioned rats.

  1979cited by this paper
• Response of central monoaminergic neurons to lisuride: comparison with LSD.

  1979cited by this paper
• Dissociations between the effects of LSD on behavior and raphe unit activity in freely moving cats.

  1979cited by this paper
• Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.

  1978cited by this paper
• The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.

  1978cited by this paper
• The discriminative stimulus properties of LSD: mechanisms of action.

  1978cited by this paper
• Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat.

  1977cited by this paper
• Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide.

  1977cited by this paper
• Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.

  1976cited by this paper
• paraChlorophenylalanine potentiates facilitatory effects of Mescaline on shuttlebox escape/avoidance in rats

  1976cited by this paper
• Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats

  1975cited by this paper
• Role of serotonin in the discriminative stimulus properties of mescaline.

  1975cited by this paper
• Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow.

  1975cited by this paper
• Effects of d- and l-amphetamine on habituation and sensitization of the acoustic startle response in rats

  1975cited by this paper
• Blockade of the stimulus properties of mescaline by a serotonin antagonist.

  1975cited by this paper
• [Effects of lysergic acid amide 25 on the startle reaction in the rat].

  1974cited by this paper
• Effects of lysergic acid diethylamide (LSD) on habituation and sensitization of the startle response in the rat.

  1974cited by this paper
• Mode of action of LSD on serotonergic neurons.

  1974cited by this paper
• Biphasic dose-response effects of N-N-dimethyltryptamine on the rat startle reflex.

  1974cited by this paper
• Effets de l'amide de l'acide lysergique-25 sur la réaction de sursaut chez le rat.

  1974cited by this paper
• Mode of action of LSD on serotonergic neurons.

  1974cited by this paper
• Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input.

  1974cited by this paper
• Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain.

  1973cited by this paper
• Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain.

  1972cited by this paper
• Action of psychotogenic drugs on single midbrain raphe neurons.

  1970cited by this paper
• Habituation of startle response under incremental sequence of stimulus intensities.

  1969cited by this paper
• Lysergic Acid Diethylamide: Sensitive Neuronal Units in the Midbrain Raphe

  1968cited by this paper
• Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.

  1967cited by this paper
• Effects of LSD-25 on brain serotonin.

  1961cited by this paper
• Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148.

  1959cited by this paper
• Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

  1956cited by this paper
• CLINICAL REACTIONS AND TOLERANCE TO LSD IN CHRONIC SCHIZOPHRENIA

  1955cited by this paper
• Involvement of 5-HT 2 Receptors in the LSD-and L-5-HTP-Induced Suppression of Lordotic B ehavior in the Female Rat

  year unknowncited by this paper

• Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation

  2022cites this paper
• Mescaline: The forgotten psychedelic.

  2022influential citation
• Dark Classics in Chemical Neuroscience: Mescaline.

  2018cites this paper
• Serotonergic hallucinogens as translational models relevant to schizophrenia.

  2013cites this paper
• Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats

  2012cites this paper
• The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety.

  2009cites this paper
• PARTICIPACION GABAERGICA Y SEROTONERGICA EN EL EFECTO ANSIOLITICO INDUCIDO POR EL NADO FORZADO

  2009cites this paper
• 5-HT1A ANTAGONISM WITHIN THE BED NUCLEUS OF THE STRIA TERMINALIS MODULATES ANXIETY-LIKE BEHAVIORS IN RATS A Thesis Presented

  2008cites this paper
• 2007 Short CourSe I What ’ s Wrong with My Mouse ? Strategies for rodent Behavior Phenotyping organized

  2007cites this paper
• Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose

  2007cites this paper
• 2007CourSe I What's Wrong with My Mouse? Strategies for rodent Behavior Phenotyping

  2007cites this paper
• The Native American Church, Peyote, and Health: Expanding Consciousness for Healing Purposes

  2007cites this paper
• Annotation The Marketing of S-Hydroxytryptamine : Depression or Anxiety ?

  2006cites this paper
• Aversive stimulus properties of the 5-HT2C receptor agonist WAY 161503 in rats.

  2006cites this paper
• The American Indian Church and its sacramental use of peyote: A review for professionals in the mental-health arena

  2005cites this paper
• The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats

  2004cites this paper
• Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients.

  2002cites this paper
• 5-Hydroxytryptamine pathways in anxiety and its treatment.

  1995cites this paper
• A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons.

  1993cites this paper
• 5-HT1 receptors and behavior.

  1992cites this paper
• Altered states of consciousness: phenomenology and pharmacology

  1992cites this paper
• (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.

  1990cites this paper
• The major hallucinogens and the central cytoskeleton: an association beyond coincidence? Towards sub-cellular mechanisms in schizophrenia.

  1990cites this paper
• Animal models for anxiety and response to serotonergic drugs.

  1989cites this paper
• Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.

  1989cites this paper
• beta-Phenylethylamines and the isoquinoline alkaloids.

  1989cites this paper